docetaxel anhydrous has been researched along with Cancer of Maxillary Sinus in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Clauditz, T; Knecht, R; Laban, S; Muenscher, A; Schafhausen, P; Tribius, S; Veldhoen, S; Zielinski, V | 1 |
Fouret, P; Handra-Luca, A; Planchard, D | 1 |
Adachi, M; Fujimoto, Y; Hagiwara, S; Lai, SY; Mitsudo, K; Shigetomi, T; Tohnai, I; Yamamoto, N | 1 |
Culliney, B; Harrison, LB; Hauerstock, D; Hu, KS; Jacobson, A; Li, Z; Manolidis, S; Mourad, WF; Persky, M; Schantz, S; Shourbaji, RA; Tran, T; Urken, M | 1 |
Kawabori, S; Taniguchi, M; Watanabe, A | 1 |
2 review(s) available for docetaxel anhydrous and Cancer of Maxillary Sinus
Article | Year |
---|---|
Management of sinonasal undifferentiated carcinoma with intracerebral invasion: Clinical experience at a single institution and review of the literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma; Chemoradiotherapy; Cisplatin; Docetaxel; Fluorouracil; Humans; Induction Chemotherapy; Magnetic Resonance Imaging; Male; Maxillary Sinus Neoplasms; Neoplasm Invasiveness; Otorhinolaryngologic Surgical Procedures; Taxoids; Tomography, X-Ray Computed | 2016 |
Trimodality management of sinonasal undifferentiated carcinoma and review of the literature.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemoradiotherapy; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Docetaxel; Female; Fluorouracil; Follow-Up Studies; Humans; Male; Maxillary Sinus Neoplasms; Middle Aged; Neoadjuvant Therapy; Preoperative Care; Retrospective Studies; Taxoids; Treatment Outcome | 2013 |
1 trial(s) available for docetaxel anhydrous and Cancer of Maxillary Sinus
Article | Year |
---|---|
Trimodality management of sinonasal undifferentiated carcinoma and review of the literature.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemoradiotherapy; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Docetaxel; Female; Fluorouracil; Follow-Up Studies; Humans; Male; Maxillary Sinus Neoplasms; Middle Aged; Neoadjuvant Therapy; Preoperative Care; Retrospective Studies; Taxoids; Treatment Outcome | 2013 |
3 other study(ies) available for docetaxel anhydrous and Cancer of Maxillary Sinus
Article | Year |
---|---|
Docetaxel-cisplatin-radiotherapy in adenoid cystic carcinoma with high-grade transformation.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenoid Cystic; Cisplatin; Combined Modality Therapy; Docetaxel; Female; Humans; Magnetic Resonance Imaging; Maxillary Sinus Neoplasms; Middle Aged; Mouth Neoplasms; Neoplasm Recurrence, Local; Radiotherapy, Conformal; Taxoids; Tomography, X-Ray Computed | 2009 |
Chemoradiotherapy for maxillary sinus adenoid cystic carcinoma using superselective intra-arterial infusion via a superficial temporal artery.
Topics: Adult; Antineoplastic Agents; Carcinoma, Adenoid Cystic; Chemoradiotherapy; Cisplatin; Docetaxel; Female; Humans; Infusions, Intra-Arterial; Male; Maxillary Sinus Neoplasms; Middle Aged; Taxoids; Temporal Arteries; Treatment Outcome | 2013 |
[A case of a 91-year-old woman with maxillary sinus carcinoma who achieved a complete response to chemoradiotherapy with intra-arterial administration of docetaxel].
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Combined Modality Therapy; Docetaxel; Female; Humans; Infusions, Intra-Arterial; Maxillary Sinus Neoplasms; Remission Induction; Taxoids | 2003 |